Blocking of Tim‐3 Ameliorates Spinal Cord Ischemia‐Reperfusion Injury Through Inhibiting Neuroinflammation and Promoting M1‐to‐M2 Phenotypic Polarization of Microglia
Immunity, Inflammation and Disease · 2024-12 · 12 (12)
DOI: 10.1002/iid3.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 06.12.2024. Verfasst von Zhenxing Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, First Affiliated Hospital of the Guangxi University of Chinese Medicine, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Microglia, Neuroinflammatory Diseases, Hepatitis A Virus Cellular Receptor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the National Natural Science Foundation of China, China (No. 81660814)., National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Blocking of Tim‐3 exerts therapeutic effects in a series of ischemia‐reperfusion injury (IRI).
Methods
In this work, a cross‐clamped aortic arch was conducted to establish SCIRI rat model. Besides, rat spinal microglia was subjected to OGD/R to mimic I/R‐like conditions in vitro. The in vivo and in vitro therapeutic effects of Tim‐3 antibody in SCIRI were investigated from these aspects: neuronal apoptosis, neuroinflammation, microglia activation, and polarization.
Results
It was verified that Tim‐3 was highly expressed in spinal cord tissues of SCIRI rats and blocking of Tim‐3 attenuated SCIRI‐induced pathological injury, neuronal apoptosis, neuroinflammation, and microglia activation (M1 polarization). In addition, it was verified that Tim‐3 was highly expressed in OGD/R‐treated rat spinal microglia and blocking of Tim‐3 attenuated OGD/R‐induced inflammation and spinal microglia activation (M1 polarization).
Conclusions
Tim‐3 antibody can exert therapeutic effects in SCIRI through inhibiting neuroinflammation and promoting microglia polarization from M1 to M2 phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation, First Affiliated Hospital of the Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
- Department of Tuina, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
- Department of Emergency, First Affiliated Hospital of the Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
ORCID-Profile: Bolin Li
Förderung
- This work was supported by the National Natural Science Foundation of China, China (No. 81660814).
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Zhou, B., Chen, G., Yang, X., Su, H., & Li, B. (2024). Blocking of Tim‐3 Ameliorates Spinal Cord Ischemia‐Reperfusion Injury Through Inhibiting Neuroinflammation and Promoting M1‐to‐M2 Phenotypic Polarization of Microglia. Immunity, Inflammation and Disease, 12(12). https://doi.org/10.1002/iid3.70084
Vancouver
Li Z, Zhou B, Chen G, Yang X, Su H, Li B. Blocking of Tim‐3 Ameliorates Spinal Cord Ischemia‐Reperfusion Injury Through Inhibiting Neuroinflammation and Promoting M1‐to‐M2 Phenotypic Polarization of Microglia. Immunity, Inflammation and Disease. 2024;12(12). doi:10.1002/iid3.70084
BibTeX
@article{Li2024,
author = {Li, Zhenxing and Zhou, Binbin and Chen, Guanghui and Yang, Xiangyu and Su, Han and Li, Bolin},
title = {Blocking of Tim‐3 Ameliorates Spinal Cord Ischemia‐Reperfusion Injury Through Inhibiting Neuroinflammation and Promoting M1‐to‐M2 Phenotypic Polarization of Microglia},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {12},
doi = {10.1002/iid3.70084}
}
EUVIMED